prt7732
·Code: PRT7732
prt7732: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Prelude Therapeutics Inc (PRLD) | Phase 1 |
Clinical Trials (1)
A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4
Frequently asked questions
Who is developing prt7732?
prt7732 is being developed by Prelude Therapeutics Inc.
How many clinical trials involve prt7732?
BioSniper tracks 1 clinical trial involving prt7732.
Get deeper analysis on prt7732
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis